Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of ...
Volant Holdings Gmbh
April 12, 2018 - N°20180099001

The present invention is directed to a system characterization of nash that combines modeling and biomarkers, enabling pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of non alcoholic fatty liver disease (nafld) and non alcoholic steatohepatitis (nash). Said conditions are liver related complications among the array of manifestations of metabolic syndromes, including type 2 ...
Amlodipine formulations
Silvergate Pharmaceuticals, Inc.
April 12, 2018 - N°20180098978

Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and coronary artery disease (cad).
Diagnostics for pulmonary arterial hypertension and sudden cardiac death
Rhode Island Hospital
April 05, 2018 - N°20180094317

This invention relates to a diagnostic test measuring circulating scn5a proteins or gene transcripts in a test sample as a biomarker for pulmonary hypertension.
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Ldl quantitation and methods of use
April 05, 2018 - N°20180092964

The present invention features, in certain aspects, methods of promoting endocytosis of ldl with α1pi or peptides derived from α1pi. The present invention also provides methods for decreasing ldl levels in response to α1pi augmentation therapy. In preferred embodiments, the methods are suitable for a subject who is suffering from a disease or disorder ...
Treprostinil derivative compounds and methods of using same
Corsair Pharma, Inc.
March 29, 2018 - N°20180086730

Compounds represented by formulae i, ii, iii, and iv including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (ph) or pulmonary arterial hypertension (pah). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
Novel therapeutic treatments using centhaquin
Midwestern University
March 29, 2018 - N°20180085461

Methods of treating hypertension, pain, and resuscitative hemorrhagic shock using an adrenergic agent, like centhaquin, are disclosed. The methods treat mammals, including humans.
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods of ablating tissue using a catheter injection system
Ablative Solutions, Inc.
March 15, 2018 - N°20180071019

At the present time, physicians often treat patients with atrial fibrillation (af) using radiofrequency (rf) catheter systems to ablate conducting tissue in the wall of the left atrium of the heart around the ostium of the pulmonary veins. These systems are expensive and take time consuming to use. The present invention circular ablation system cas includes a multiplicity of expandable ...
Arterial wall compression stent
March 15, 2018 - N°20180070954

A compression stent for applying a localized high stress against a blood vessel wall to cause vessel wall compression and blockage of sympathetic and nerve signal transmission within the wall of a blood vessel. The compression stent can also sever nerves located in the vessel wall. Blockage of sympathetic nerve signal transmission reduces hypertension and improves other clinical problems that ...
Isolation of pulmonary arterial endothelial cells from patients with pulmonary vascular disease and uses thereof
Allegheny-singer Research Institute
March 08, 2018 - N°20180067104

The present disclosure provides methods of obtaining, recovering and culturing pulmonary arterial endothelial cells from an individual patient subjected to a right heart catheterization in regard to diagnosis of pulmonary hypertension. These isolated pulmonary arterial endothelial cells from an individual patient may be utilized to generate cellular phenotyping profile for the cell population, allowing generation of a personalized pharmacotherapy regime ...
Method of treating hypertension
Cipla Limited
March 08, 2018 - N°20180064699

Disclosed herein are compositions and methods for the treatment of pulmonary hypertension, including pulmonary arterial hypertension. The methods include administering to a patient in need thereof an effective amount of cinitapride or derivative thereof. The compositions include an effective amount of cinitapride or derivative thereof, in some instances combined with one or more additional agents for the treatment of pulmonary ...
Therapeutic cd47 antibodies
Tioma Therapeutics, Inc.
March 01, 2018 - N°20180057592

Provided are monoclonal antibodies and antigen-binding fragments thereof that bind to cd47 of multiple mammalian species, block the binding of sirpalpha and tsp1 to cd47, promote phagocytosis of susceptible cancer cells, and reverse tsp1 inhibition of nitric oxide signaling, as well as monoclonal antibodies and antigen binding fragments thereof that compete with the former for binding to cd47 and that ...
Anti-gremlin-1 (grem1) antibodies and methods of use thereof for treating pulmonary arterial hypertension
Regeneron Pharmaceuticals, Inc.
March 01, 2018 - N°20180057580

The present invention provides anti-gremlin-1 (grem1) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (pah).
System and method for optogenetic therapy
Circuit Therapeutics, Inc.
March 01, 2018 - N°20180056085

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic cd47 antibodies
Tioma Therapeutics, Inc.
February 22, 2018 - N°20180051081

Provided are monoclonal antibodies and antigen-binding fragments thereof that bind to cd47 of multiple mammalian species, block the binding of sirpalpha and tsp1 to cd47, promote phagocytosis of susceptible cancer cells, and reverse tsp1 inhibition of nitric oxide signaling, as well as monoclonal antibodies and antigen binding fragments thereof that compete with the former for binding to cd47 and that ...
N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
Cardioxyl Pharmaceuticals, Inc.
February 22, 2018 - N°20180050985

The invention provides certain n-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or develop of a disease or condition. In some embodiments, the disease or condition ...
Compositions and methods for treating pulmonary hypertension
Acceleron Pharma Inc.
February 22, 2018 - N°20180050089

In some aspects, the disclosure relates to gdf/bmp antagonists and methods of using gdf/bmp antagonists to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension (ph), particularly treating, preventing or reducing the progression rate and/or severity of one or more ph-associated complications. The disclosure also provides methods of using a gdf/bmp antagonist ...
Ifetroban treatment of portal hypertension
Cumberland Pharmaceuticals, Inc.
February 22, 2018 - N°20180050020

The present invention is directed to methods of treating and/or ameliorating portal hypertension by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
Vascular calcification prevention and treatment
Summit Innovation Labs Llc
February 15, 2018 - N°20180042962

The invention encompasses compositions and methods for effectively interfering, reducing and preventing conversion of vascular smooth muscle cells (vsmcs) and circulating stem cells to osteoblastic bone-like cells, thereby reducing and/or preventing vascular calcification (vc) or calcium mineral (hydroxyapatite) deposition in the vasculature. The severity and extent of calcification in the major arteries reflect atherosclerotic plaque burden and strongly predict ...
Metabolic syndrome treatment
Arkay Therapeutics, Llc
February 15, 2018 - N°20180042945

Formulations and methods of providing an orally-active anti-metabolic disease fixed dose combinations (fdc) for use as personalized medicine to treat different components of the metabolic syndrome or insulin resistance syndrome such as type ii diabetes, hypertension, hyperlipidemia and obesity are disclosed. Pharmaceutical compositions of anti-inflammatory centric drug formulations and methods comprising of nsaids in general and selective cox-2 inhibitors in ...
Methods of treating cancers, autoimmune disorders, and other conditions associated with chronic inflammation
Mymd Pharmaceuticals, Inc.
February 15, 2018 - N°20180042909

In one aspect, a method of treating a disorder associated with chronic inflammation includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In some aspects, the disorder is a cancer, an autoimmune disorder, hypertension, or autism. In other aspects, isomyosmine is administered to treat viral infections or disorders associated ...
Systems and methods for treating pulmonary hypertension
Aria Cv, Inc.
February 08, 2018 - N°20180036464

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e. G., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and ...
Loading